This collection is supposed to be open access, but it does not appear that they have done that yet. If anyone would like a copy of the articles, please let me know.
The substantive focus (synthetic biology) is not directly on point for this group — but the discussion of the strengths and weaknesses of cost-benefit analysis (and other policy analytic tools from welfare economics) may be of interest to many and we would enjoy hearing your reactions!
Thanks to Adam for sharing this.
Sent from my iPhone
> On Feb 18, 2018, at 1:30 PM, Oliver,AJ <[log in to unmask]> wrote:
> Interesting new Hastings Center Report on the governance of emerging technologies, and challenges to cost benefit analysis in that area: